Chosa ApS: Financial statements 2023
CVR: 43134477
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Chosa ApS (CVR 43134477) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,542,553 and a net result of DKK -2,069,955. Equity in the 2023 report amounted to DKK 8,991,145. The solvency ratio was 87.3%.
- Gross Profit
- DKK -1,542,553
- Profit/Loss
- DKK -2,069,955
- Equity
- DKK 8,991,145
- Total Assets
- DKK 10,294,826
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Chosa ApS has published its interim report for the period March 18, 2022 – December 31, 2022.
As of January 18, 2023, is registered as an owner of Chosa ApS with an ownership share of 100%.
About Chosa ApS
Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Peter Buhl and Claus Frisenberg Pedersen. The company is owned by Chosa Oncology AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity in the 2025 report amounted to DKK 5,175,030.